Medical device manufacturer Boston Scientific has introduced LithoVue single-use digital flexible ureteroscope in the US and Europe.


The LithoVue system has been developed to carry out minimally invasive endoscopic procedures to diagnose and treat stones and other conditions of the kidney, ureter and bladder.

According to the company, it has designed the LithoVue system to provide enhanced digital visualization and navigation for consistent clinical performance during each patient procedure.

With a digital CMOS imager in the 7.7F tip, LithoVue captures quality images across a depth of field compared to other commonly used reusable scopes.

The system’s full 270 degree scope deflection in both directions is said to offer accurate navigation toward the targeted treatment area.

It also features workstation monitor with integrated image processing software on a compact and rolling mobile cart, which can be used alone during a ureteroscopic procedure or connected to existing monitors and integrated video systems in the operating room suite.

Boston Scientific urology and pelvic health president and senior vice-president Karen Prange said: "At Boston Scientific, we are committed to providing innovative solutions to the healthcare challenges that our customers face every day.

"The LithoVue System is an example of how we are focused on addressing unmet needs by providing urologists and hospitals a predictable, cost-effective, minimally invasive endoscope for the management of kidney stones."

The LithoVue system is also commercially available in New Zealand.

In December, Boston Scientific also obtained US Food and Drug Administration (FDA) and CE mark approval for its AngioJet ZelanteDVT thrombectomy catheter to treat deep vein thrombosis (DVT) in large-diameter upper and lower limb peripheral veins.

Image: Boston Scientific’s LithoVue single-use digital flexible ureteroscope. Photo: courtesy of Boston Scientific Corporation.